Secondhand Tobacco Smoke and Cardiovascular Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT04715568

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04715568
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04715568. Randomized; quadruple masking; primary purpose treatment. Start 2021-03-30 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Secondhand Tobacco Smoke and Cardiovascular Disease
Condition
Cardiovascular Diseases
Condition
Hypertension
Intervention (Drug)
Losartan
Intervention (Drug)
Placebo
Lead sponsor
University of California, San Francisco (class: other)
Collaborator
Flight Attendant Medical Research Institute (class: other)

Record details

Record id
cardio:ct-nct04715568
Content hash
f926bd36ace1e67604b7d72eec314e3dc7fad9069cf963849309ff1581e783b8